Literature DB >> 22563180

Analysis of infections in the first 3-month after living donor liver transplantation.

Chuan Li1, Tian-Fu Wen, Kai Mi, Chuan Wang, Lu-Nan Yan, Bo Li.   

Abstract

AIM: To identify factors related to serious postoperative bacterial and fungal infections in the first 3 mo after living donor liver transplantation (LDLT).
METHODS: In the present study, the data of 207 patients from 2004 to 2011 were reviewed. The pre-, intra- and post-operative factors were statistically analyzed. All transplantations were approved by the ethics committee of West China Hospital, Sichuan University. Patients with definitely preoperative infections and infections within 48 h after transplantation were excluded from current study. All potential risk factors were analyzed using univariate analyses. Factors significant at a P < 0.10 in the univariate analyses were involved in the multivariate analyses. The diagnostic accuracy of the identified risk factors was evaluated using receiver operating curve.
RESULTS: The serious bacterial and fungal infection rates were 14.01% and 4.35% respectively. Enterococcus faecium was the predominant bacterial pathogen, whereas Candida albicans was the most common fungal pathogen. Lung was the most common infection site for both bacterial and fungal infections. Recipient age older than 45 years, preoperative hyponatremia, intensive care unit stay longer than 9 d, postoperative bile leak and severe hyperglycemia were independent risk factors for postoperative bacterial infection. Massive red blood cells transfusion and postoperative bacterial infection may be related to postoperative fungal infection.
CONCLUSION: Predictive risk factors for bacterial and fungal infections were indentified in current study. Pre-, intra- and post-operative factors can cause postoperative bacterial and fungal infections after LDLT.

Entities:  

Keywords:  Bacterial infection; Fungal infection; Living donor liver transplantation

Mesh:

Year:  2012        PMID: 22563180      PMCID: PMC3337575          DOI: 10.3748/wjg.v18.i16.1975

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  37 in total

Review 1.  Invasive fungal infections in liver transplantation.

Authors:  Xia Liu; Zongxin Ling; Lanjuan Li; Bing Ruan
Journal:  Int J Infect Dis       Date:  2011-02-22       Impact factor: 3.623

2.  Evaluation and treatment of intraabdominal bilomas.

Authors:  J L Vazquez; M K Thorsen; W J Dodds; F A Quiroz; M L Martinez; T L Lawson; E T Stewart; W D Foley
Journal:  AJR Am J Roentgenol       Date:  1985-05       Impact factor: 3.959

Review 3.  The model for end-stage liver disease (MELD).

Authors:  Patrick S Kamath; W Ray Kim
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

4.  Outcome of liver transplantation in patients with diabetes mellitus: a case-control study.

Authors:  P R John; P J Thuluvath
Journal:  Hepatology       Date:  2001-11       Impact factor: 17.425

5.  Microsurgical reconstruction of hepatic artery in A-A LDLT: 124 consecutive cases without HAT.

Authors:  Yi Yang; Lu-Nan Yan; Ji-Chun Zhao; Yu-Kui Ma; Bin Huang; Bo Li; Tian-Fu Wen; Wen-Tao Wang; Ming-Qing Xu; Jia-Yin Yang
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

6.  Nosocomial bloodstream infections in ICU and non-ICU patients.

Authors:  Vesna Suljagić; Miloje Cobeljić; Slavenka Janković; Veljko Mirović; Ljiljana Marković-Denić; Predrag Romić; Dragan Mikić
Journal:  Am J Infect Control       Date:  2005-08       Impact factor: 2.918

7.  Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation.

Authors:  Chulsoo Park; Chehao Hsu; Gundappa Neelakanta; Hamid Nourmand; Michelle Braunfeld; Christopher Wray; Randolph H Steadman; Ke-Qin Hu; Ronald T Cheng; Victor W Xia
Journal:  Transplantation       Date:  2009-04-15       Impact factor: 4.939

8.  Risk factors for Enterobacteriaceae bacteremia after liver transplantation.

Authors:  Claire Bellier; Frédéric Bert; François Durand; Sylvie Retout; Jacques Belghiti; France Mentré; Bruno Fantin
Journal:  Transpl Int       Date:  2008-04-23       Impact factor: 3.782

9.  Infectious complications in living-donor liver transplant recipients: a 9-year single-center experience.

Authors:  Y J Kim; S I Kim; S H Wie; Y R Kim; J A Hur; J Y Choi; S K Yoon; I S Moon; D G Kim; M D Lee; M W Kang
Journal:  Transpl Infect Dis       Date:  2008-05-26       Impact factor: 2.228

10.  Hyponatremia and hospital outcomes among patients with pneumonia: a retrospective cohort study.

Authors:  Marya D Zilberberg; Alex Exuzides; James Spalding; Aimee Foreman; Alison Graves Jones; Chris Colby; Andrew F Shorr
Journal:  BMC Pulm Med       Date:  2008-08-18       Impact factor: 3.317

View more
  17 in total

1.  Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients.

Authors:  Marcus R Pereira; Brendan F Scully; Stephanie M Pouch; Anne-Catrin Uhlemann; Stella Goudie; Jean E Emond; Elizabeth C Verna
Journal:  Liver Transpl       Date:  2015-12       Impact factor: 5.799

2.  Contribution of (1,3)-beta-D-glucan to diagnosis of invasive candidiasis after liver transplantation.

Authors:  E Levesque; S El Anbassi; E Sitterle; F Foulet; J C Merle; F Botterel
Journal:  J Clin Microbiol       Date:  2014-12-17       Impact factor: 5.948

3.  Living Donor Liver Transplantation in South Asia: Single Center Experience on Intermediate-Term Outcomes.

Authors:  Faisal S Dar; Abu Bakar H Bhatti; Ammal I Qureshi; Nusrat Y Khan; Zahaan Eswani; Haseeb H Zia; Eitzaz U Khan; Nasir A Khan; Atif Rana; Najmul H Shah; Mohammad Salih; Rashid Nazer
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

4.  Infections developing in patients undergoing liver transplantation: Recipients of living donors may be more prone to bacterial/fungal infections.

Authors:  Tansu Yamazhan; Cansu Bulut Avşar; Murat Zeytunlu; Meltem Taşbakan; Rüçhan Sertöz; Ayşın Zeytinoğlu; Şöhret Aydemir; Ömer Ünalp; Orkan Ergün; Alper Uğuz; Funda Özgenç; Fulya Günşar; İlker Turan; Sezgin Ulukaya; Nuri Deniz; Funda Yilmaz; Deniz Nart; Ezgi Güler; Kutsal Turhan; Zeki Karasu
Journal:  Turk J Gastroenterol       Date:  2020-12       Impact factor: 1.852

5.  Living donor liver transplantation for high model for end-stage liver disease score: What have we learned?

Authors:  Hany Dabbous; Mohammad Sakr; Sara Abdelhakam; Iman Montasser; Mohamed Bahaa; Hany Said; Mahmoud El-Meteini
Journal:  World J Hepatol       Date:  2016-08-08

6.  Probiotic use in preventing postoperative infection in liver transplant patients.

Authors:  Yan Zhang; Jim Chen; Jinshan Wu; Helen Chalson; Lynn Merigan; Andrew Mitchell
Journal:  Hepatobiliary Surg Nutr       Date:  2013-06       Impact factor: 7.293

Review 7.  [Liver transplantation with living donor : current aspects, perspectives and significance in Germany].

Authors:  U Settmacher; A Bauschke; C Malessa; H Scheuerlein; J Zanow; F Rauchfuß
Journal:  Chirurg       Date:  2013-05       Impact factor: 0.955

Review 8.  Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge.

Authors:  Guilherme Santoro-Lopes; Erika Ferraz de Gouvêa
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

Review 9.  Bacterial infection after liver transplantation.

Authors:  Sang Il Kim
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

10.  Risk factors and outcomes for patients with bloodstream infection due to Acinetobacter baumannii-calcoaceticus complex.

Authors:  Teena Chopra; Dror Marchaim; Paul C Johnson; Reda A Awali; Hardik Doshi; Indu Chalana; Naomi Davis; Jing J Zhao; Jason M Pogue; Sapna Parmar; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.